5 min read
SciNote LLC, one of the leading companies in the field of laboratory digitalization, whose product, an electronic lab notebook (ELN) is among the top 3 of its kind, is publishing its new brand identity today.
1 min read
An alarming study showed that out of 238 published scientific articles, barely 46% could be reproduced. News also reported on the replication efforts which were successful for only two of five cancer papers.
3 min read
We are happy to announce that this release brings SciNote integration with a premium version of the chemical drawing tool by ChemAxon.
10 min read
Being an expert in the field of diet research, you come to the point in your career where you need to run a controlled clinical trial, include thousands of people who are willing to turn their eating habits upside down and convince the government to give you hundreds of thousands of dollars to do it.
2 min read
Available for every scientist today, this open access repository of research protocols is both free to read, and free to publish.
4 min read
In this article, we will explain how we approach the ELN implementation process and give you some good practice suggestions on how to handle the adoption of an ELN successfully in your lab.
1 min read
We know that implementing an ELN is not an eays task and often it takes quite some time and effort for the entire team to get on board. Therefore, SciNote Academy will offer free, self-paced courses to all interested SciNote users.
10 min read
From the sample that comes in the lab, to the automatically generated report at the end, an electronic lab notebook (ELN) can help your lab to manage all data in compliance with the highest standards in scientific data management.
1 min read
Previous week, Jure Kumljanc, SciNote’s Vice President of Marketing, headed to Germany to attend LABVOLUTION, where he got a closer look at the latest developments in the field of connected laboratories.
1 min read
Last week Zala Kobe, our Key Account Manager, attended the Swiss Biotech Day, an annual meetup of the Swiss biopharmaceutical industry. And Basel, as one of the most vivid cities in terms of biotechnological and pharmaceutical research, development and production, proved to be the ideal location.
